DE69942200D1 - Parvovirus NS1 Varianten - Google Patents

Parvovirus NS1 Varianten

Info

Publication number
DE69942200D1
DE69942200D1 DE69942200T DE69942200T DE69942200D1 DE 69942200 D1 DE69942200 D1 DE 69942200D1 DE 69942200 T DE69942200 T DE 69942200T DE 69942200 T DE69942200 T DE 69942200T DE 69942200 D1 DE69942200 D1 DE 69942200D1
Authority
DE
Germany
Prior art keywords
parvovirus
variants
relates
dnas
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69942200T
Other languages
English (en)
Inventor
Juerg Dr Nueesch
Jean Prof Dr Rommelaere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ filed Critical Deutsches Krebsforschungszentrum DKFZ
Application granted granted Critical
Publication of DE69942200D1 publication Critical patent/DE69942200D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69942200T 1999-08-13 1999-08-13 Parvovirus NS1 Varianten Expired - Lifetime DE69942200D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99115161A EP1077260B1 (de) 1999-08-13 1999-08-13 Parvovirus NS1 Varianten

Publications (1)

Publication Number Publication Date
DE69942200D1 true DE69942200D1 (de) 2010-05-12

Family

ID=8238701

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69942200T Expired - Lifetime DE69942200D1 (de) 1999-08-13 1999-08-13 Parvovirus NS1 Varianten

Country Status (6)

Country Link
US (1) US6919196B1 (de)
EP (1) EP1077260B1 (de)
AT (1) ATE462791T1 (de)
DE (1) DE69942200D1 (de)
ES (1) ES2343394T3 (de)
WO (1) WO2001012666A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1473306A1 (de) 2003-04-30 2004-11-03 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Als cytotoxin geeignetes fusionspolypeptid
ITRM20040561A1 (it) 2004-11-11 2005-02-11 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
EP2268801A4 (de) * 2008-03-14 2011-12-28 Us Gov Health & Human Serv Zusammensetzungen und verfahren in verbindung mit dem menschlichen bocavirus
EP2384761B1 (de) * 2010-05-07 2013-09-04 Deutsches Krebsforschungszentrum Modifiziertes Nagetier-Parvovirus, das sich durch menschliche Glioma vermehren und ausbreiten kann
EP2404609A1 (de) 2010-07-07 2012-01-11 Deutsches Krebsforschungszentrum Verwendung vom Parvovirus zur Beseitigung von Krebsstammzellen
TW202336236A (zh) * 2015-03-27 2023-09-16 美商再生元醫藥公司 偵測生物污染物之組成物及方法
EP3738972A1 (de) 2019-05-13 2020-11-18 Deutsches Krebsforschungszentrum Parvolysin

Also Published As

Publication number Publication date
ES2343394T3 (es) 2010-07-29
US6919196B1 (en) 2005-07-19
EP1077260B1 (de) 2010-03-31
EP1077260A1 (de) 2001-02-21
ATE462791T1 (de) 2010-04-15
WO2001012666A1 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
ATE445376T1 (de) Schraube zur befestigung der wirbelsäule
AP2212A (en) Phosphonates, Monophosphonamidates, Bisphosphonamidates for the treatment of viral diseases.
MXPA03010909A (es) Derivados de epotilona.
DE60236367D1 (de) Echolöscher, der eine weitere reduktion des restechos sicherstellt
HUP0101594A2 (hu) Parathormon alkalmazása csontkeménység és csontszilárdság növelésére, valamint csonttörések csökkentésére
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
ZA200702523B (en) Process for the purification of 1,4-butanediol
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
ATE402987T1 (de) Klebestruktur zur befestigung auf der haut
DK1264603T3 (da) Anvendelse af L-polynukleotider til in vivo-billeddannelse
MXPA03009478A (es) Mezclas con resistencia al impacto modificada de poli (tereftalato de etileno) y al menos un policarbonato basado en dihidroxidiarilciclohexano.
BR0108826B1 (pt) processo para a produção de uma zeólita contendo titánio, zeólita contendo titánio assim obtida, processo para a epoxidação de olefinas e uso da referida zeólita.
ATE462791T1 (de) Parvovirus ns1 varianten
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
WO2002081745A3 (en) Genes involved in osteogenesis, and methods of use
BR0115991A (pt) Processo para o isolamento e a purificação de epotilonas
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
IT1313009B1 (it) Processo per la rigenerazione di catalizzatori zeolitici.
PT1453820E (pt) 6h-dibenzo[c,h]cromenos como agentes estrogenicos
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
AU2003227593A1 (en) New analogs of nitrobenzylthioinosine
PL1612210T3 (pl) Nowe analogi nitrobenzylotioinozyny
ATE345818T1 (de) S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition